Narrow your search

Library

AP (1)

KDG (1)

KU Leuven (1)

Odisee (1)

Thomas More Kempen (1)

Thomas More Mechelen (1)

UCLL (1)

UGent (1)

ULB (1)

ULiège (1)

More...

Resource type

book (1)

digital (1)


Language

English (2)


Year
From To Submit

2016 (2)

Listing 1 - 2 of 2
Sort by

Book
Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders
Authors: ---
ISBN: 3319270389 3319270400 Year: 2016 Publisher: Cham : Springer International Publishing : Imprint: Adis,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.


Digital
Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders
Authors: ---
ISBN: 9783319270401 Year: 2016 Publisher: Cham Springer International Publishing, Imprint: Adis

Loading...
Export citation

Choose an application

Bookmark

Abstract

Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.

Listing 1 - 2 of 2
Sort by